trending Market Intelligence /marketintelligence/en/news-insights/trending/MQWYgykt0VmfPn_CH6YsCw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

OrthoPediatrics prices common stock offering of 1,570,000 shares

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

OrthoPediatrics prices common stock offering of 1,570,000 shares

OrthoPediatrics Corp. priced an underwritten public offering of 1,570,000 of its shares at $36.50 apiece.

The Warsaw, Ind.-based medical device company is offering 1,520,000 of its shares directly. OrthoPediatrics' stockholders will offer an additional 50,000 shares, the proceeds of which will not go to the company.

Underwriters will receive an option to buy up to an additional 235,500 shares.

The offering is scheduled to close Dec. 13.

Piper Jaffray and Stifel are joint book-running managers for the offering, while BTIG, JMP Securities and SunTrust Robinson Humphrey are acting as co-managers.

In August, the U.S. Food and Drug Administration approved OrthoPediatrics' PediFoot Deformity Correction System, which treats foot and ankle deformities in children.